Sterling Capital Management’s Connect Biopharma Holdings CNTB Stock Holding History

Sterling Capital Management’s Portfolio CNTB Stock Details CNTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$357	Buy	+150	New	+$364	﹤0.01%	3240

Other funds holding CNTB

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return

David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

Sterling Capital Management's CNTB Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Connect Biopharma Holdings (CNTB) in Q2 2026: 150 shares worth $357. The stake represents ﹤0.01% of the portfolio and ranks #3240 among its holdings.

56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

Sterling Capital Management held 150 shares of Connect Biopharma Holdings worth $357 as of Q2 2026.
Connect Biopharma Holdings was a new Sterling Capital Management position in Q2 2026.
Connect Biopharma Holdings made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3240 holding.
56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.